Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
about
Maintenance agonist treatments for opiate-dependent pregnant womenOpioids in pregnancy and neonatal abstinence syndromeThe opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.Commentary on Mactier et al. (2014): Methadone-assisted treatment and the complexity of influences on fetal development.Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National GuidanceSafety of the newer class of opioid antagonists in pregnancy.Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy.Whole-genome expression profile in zebrafish embryos after chronic exposure to morphine: identification of new genes associated with neuronal function and mu opioid receptor expression.Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learnedPrenatal Substance Use: Exploring Assumptions of Maternal UnfitnessBirth and Neonatal Outcomes Following Opioid Use in Pregnancy: A Danish Population-Based Study.A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal OutcomesNeonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations.Buprenorphine use in pregnant opioid users: a critical review.Pharmacological Management of Opioid Use Disorder in Pregnant Women.Opioid use disorder during pregnancy in Tennessee: expediency vs. science.Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and GynecoTreating opioid use disorders during pregnancy: historical, current, and future directions.Experiences of opioid-dependent women in their prenatal and postpartum care: Implications for social workers in health care.Factors associated with buprenorphine versus methadone use in pregnancy.Sécurité de la plus récente classe d’antagonistes des opioïdes durant la grossesse.Newborn birth-weight of pregnant women on methadone or buprenorphine maintenance treatment: A national contingency management approach trial.Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study.P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine.The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age.Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.
P2860
Q24201642-28F08452-6DEC-47E2-B772-F5FC847BD0A3Q28082706-C17D7F7F-5672-47BF-AB96-0C6CC18819A1Q30239085-8755866D-8F1B-44A7-B7F2-D153F987C6EBQ30619876-E8D98A15-C481-40A5-A3E4-AE196E12918EQ33582025-C499E9EA-09B9-4DAC-8740-9DF76B68C638Q33678149-6393D190-11F0-4516-82E1-9693083F4716Q33760424-6ADCB08E-F855-4890-AD9A-E4B5B51BB43BQ33894730-513DEAD9-B1B6-4F82-AB8C-59C149050A1FQ33982854-B35F4BCA-FBF5-4856-98FC-616281DA28FFQ34363541-E798C6E4-6D18-4492-89A3-9FAA631EC97DQ35220378-6BA12B51-1312-4A9F-9064-37F5C6D4E358Q35835534-4DB2F195-4D56-4728-8644-F129528F2561Q36082448-1992EF8C-CFFC-4F9F-A9CC-63C1A49D9E17Q36142245-3C21CBE1-BA46-4C5C-A83D-ED3FCA6D2559Q36702592-84ED7D43-966A-4D06-ABC1-50E3CA0DCFCCQ36730570-3FC507F6-6AAF-4980-9F59-7E8670182326Q37433241-F8FA1EA3-CCBD-4A8E-9F81-35D41C1E62E3Q38115201-FF4C16FA-D743-409D-AD69-7CCC7B4A6E5DQ38575591-CFA51B0B-29B7-4D00-80A0-5C8D5813B014Q38983591-03A8119C-D814-4598-87CA-3566316A0E12Q39359619-90B2A6A4-1131-4ACF-83CF-CF219571563FQ39436476-78EF08B0-34B4-420F-B23D-EDEF7D01DE64Q40155003-E6C18AC4-6470-47DF-B14F-1BD82F844C1BQ40777859-DB6FC483-8101-4497-B40C-D630644B75A5Q45814246-A5B66EBD-7161-4461-A7D8-E928985A2662Q47235843-68EF1DB4-D600-411A-BF6E-41EA359184F6Q47574178-DCCFD2FF-9031-446B-8CDF-C44C9770B8A7Q47988249-C33C2365-F0F6-401B-BF86-7C20027C9CF8Q48133066-3D9B502B-62FC-4AE0-B314-28B5284A1EA1Q53081955-E27CA3A0-A4F3-48B1-947B-32A4A0C73E57
P2860
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
@ast
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
@en
type
label
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
@ast
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
@en
prefLabel
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
@ast
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
@en
P2093
P2860
P50
P1433
P1476
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
@en
P2093
Andjela Baewert
Gabriele Fischer
Karol Kaltenbach
Mara G Coyle
Peter R Martin
Peter Selby
Sarah H Heil
P2860
P356
10.1111/J.1360-0443.2012.04035.X
P407
P478
107 Suppl 1
P577
2012-11-01T00:00:00Z